Clinical Trials Microdosing Research and Development 
LifeCannMD
MAY 27, 2025
” I completely understand this concern, and that’s exactly why I’m passionate about educating patients about microdosing cannabis. Three months later, after starting with microdosing marijuana , she’s managing her pain effectively while maintaining complete clarity during her teaching day.
LifeCannMD
MAY 27, 2025
In the 1990s cannabis based researchers discovered that we all possess this whole-body, internal system designed to work with the compounds of medical marijuana and CBD. The growers didn’t just stumble onto thisthey carefully developed it with one goal in mind: maximum therapeutic benefit with zero psychoactive effects.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Miss Marijuana
JANUARY 30, 2025
Latest Research and Clinical Studies Now, let’s talk about science! Some research suggests that cannabis could be an effective option for managing anxiety, especially in lower doses. Some research suggests that cannabis could be an effective option for managing anxiety, especially in lower doses. But high doses?
Otherside Farms
JANUARY 16, 2019
Microdosing, if you have not yet heard of it, is hotter than just any ordinary trend: Science proves THC and CBD safe, with very real benefits associated with consuming very low doses regularly, as opposed to massive doses all at once. People are microdosing psychedelics, vitamins, near everything for health purposes.
Cannabis Law Report
JULY 25, 2022
together with research collaborators at the University of Auckland , have received NZ$1.44 million ($650,000) in funding from New Zealand’s Health Research Council (HRC) to conduct a LSD microdosing trial in patients with Major Depressive Disorder (MDD). mentalhealth #help #lsd #menta … [link].
Cannabis Law Report
JULY 13, 2022
Their position as therapeutic practitioners, as well as their work in conducting the kind of clinical trials necessary to advance regulatory outcomes for psychedelic medicines, make them ideal partners in alignment with Optimi’s strategic goals.”. VANCOUVER, British Columbia, July 13, 2022 (GLOBE NEWSWIRE) — Optimi Health Corp. (
Cannabis Law Report
MAY 12, 2022
Microdose report. Two United States Senators have sent a letter to the leadership of federal agencies asking for an update and pushing for advancement on research into psychedelics. What are the regulatory barriers to research on psychedelics? They also ask for specifics, showing that this is more than just for show.
Expert insights. Personalized for you.
Let's personalize your content